Drugs Made In America Acquisition Corp
DMAAU10.400USD
-0.180-1.70%
交易中 （美東）報價延遲15分鐘
0.00總市值
--本益比TTM
關於 Drugs Made In America Acquisition Corp 公司
Drugs Made In America Acquisition Corp. 是一家空白支票公司。該公司成立爲豁免公司，旨在與一家或多家企業進行合併、股份交換、資產收購、股份購買、資本重組、重組或其他類似的業務合併。該公司尋找潛在目標企業的努力不會侷限於特定行業或地理區域，儘管該公司打算專注於尋找製藥行業的業務合併目標。
公司簡介
公司代碼DMAAU
公司名稱Drugs Made In America Acquisition Corp
上市日期Jan 28, 2025
CEOMs. Lynn Stockwell
員工數量- -
證券類型Unit
年結日- -
公司地址1 East Broward Boulevard
城市FT LAUDERDALE
上市交易所NASDAQ Global Market Consolidated
國家United States of America
郵編33301
電話19548703099
網址
公司代碼DMAAU
上市日期Jan 28, 2025
CEOMs. Lynn Stockwell
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Dr. G. Sridhar Prasad
Dr. G. Sridhar Prasad
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Myron W. Shulgan
Mr. Myron W. Shulgan
Independent Director Nominee
Independent Director Nominee
--
--
Ms. Lynn Stockwell
Ms. Lynn Stockwell
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
--
--
Mr. Glenn C. Worman
Mr. Glenn C. Worman
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Catherine Do
Dr. Catherine Do
Independent Director Nominee
Independent Director Nominee
--
--
名稱
名稱/職務
職務
持股
持股變動
Dr. G. Sridhar Prasad
Dr. G. Sridhar Prasad
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Myron W. Shulgan
Mr. Myron W. Shulgan
Independent Director Nominee
Independent Director Nominee
--
--
Ms. Lynn Stockwell
Ms. Lynn Stockwell
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
--
--
Mr. Glenn C. Worman
Mr. Glenn C. Worman
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Catherine Do
Dr. Catherine Do
Independent Director Nominee
Independent Director Nominee
--
--
收入明細
暫無數據
暫無數據
業務
地區
暫無數據
股東統計
更新時間: 5月17日 週六
更新時間: 5月17日 週六
持股股東
股東類型
持股股東
持股股東
佔比
Drugs Made In America Acquisition LLC
17.88%
Heights Capital Management, Inc.
2.77%
Boothbay Fund Management, LLC
2.58%
Westchester Capital Management, LLC
2.13%
RiverNorth Capital Management LLC
1.79%
Other
72.84%
持股股東
持股股東
佔比
Drugs Made In America Acquisition LLC
17.88%
Heights Capital Management, Inc.
2.77%
Boothbay Fund Management, LLC
2.58%
Westchester Capital Management, LLC
2.13%
RiverNorth Capital Management LLC
1.79%
Other
72.84%
股東類型
持股股東
佔比
Corporation
17.88%
Investment Advisor/Hedge Fund
7.68%
Hedge Fund
3.54%
Investment Advisor
2.85%
Research Firm
0.03%
Other
68.02%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
20
7.49M
31.98%
+7.31M
2025Q1
20
7.60M
32.43%
+7.41M
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Drugs Made In America Acquisition LLC
4.19M
17.88%
+4.19M
--
Feb 18, 2025
Heights Capital Management, Inc.
650.00K
2.77%
+650.00K
--
Mar 31, 2025
Boothbay Fund Management, LLC
603.75K
2.58%
+603.75K
--
Mar 31, 2025
Westchester Capital Management, LLC
500.00K
2.13%
+500.00K
--
Mar 31, 2025
RiverNorth Capital Management LLC
420.50K
1.79%
+418.00K
+16719.92%
Mar 31, 2025
Context Capital Management LLC
250.00K
1.07%
+250.00K
--
Mar 31, 2025
Schonfeld Strategic Advisors LLC
234.83K
1%
+234.83K
--
Mar 31, 2025
Bulldog Investors, LLP
130.26K
0.56%
+130.26K
--
Mar 31, 2025
Wolverine Asset Management, LLC
130.00K
0.55%
+130.00K
--
Mar 31, 2025
Verition Fund Management LLC
100.00K
0.43%
+100.00K
--
Mar 31, 2025
查看更多
持股ETF
更新時間: 8月2日 週六
更新時間: 8月2日 週六
機構名稱
佔比
SPAC and New Issue ETF
2.39%
RiverNorth Enhanced Pre-Merger SPAC ETF
0.51%
CrossingBridge Pre-Merger SPAC ETF
0%
SPAC and New Issue ETF
佔比2.39%
RiverNorth Enhanced Pre-Merger SPAC ETF
佔比0.51%
CrossingBridge Pre-Merger SPAC ETF
佔比0%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
